Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: September 24, 2022

Details for Patent: 9,592,252

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Which drugs does patent 9,592,252 protect, and when does it expire?

Patent 9,592,252 protects PLENVU and is included in one NDA.

This patent has sixty-six patent family members in thirty-three countries.

Summary for Patent: 9,592,252
Abstract: The invention provides a colon cleansing solution comprising: a) 300 to 2000 mmol per liter ascorbate anion provided by ascorbic acid, one or more salts of ascorbic acid, or a mixture thereof; and b) 10 to 200 g per liter polyethylene glycol. The invention also provides methods and kits associated with, or making use of the solutions. The invention also provides a method of cleansing the colon of a subject comprising: --administering to the subject an effective amount of a first cleansing solution; and then after a time interval --administering to the subject an effective amount of a second cleansing solution, where in the two cleansing solutions are as described in the specification.
Inventor(s): Halphen; Marc (London, GB), Gruss; Hans-Jurgen (London, GB), Cox; Ian (London, GB), Cockett; Alasdair (London, GB), Stein; Peter (Amsterdam, NL), Ungar; Alex (Wigton, GB)
Assignee: NORGINE BV (Amsterdam Zuid-Oost, NL)
Application Number:14/004,604
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,592,252
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound; Device;

Drugs Protected by US Patent 9,592,252

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Salix PLENVU ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate FOR SOLUTION;ORAL 209381-001 May 4, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y FOR CLEANSING OF THE COLON IN PREPARATION FOR COLONOSCOPY IN ADULTS See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,592,252

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom1104200.9Mar 11, 2011
United Kingdom1104202.5Mar 11, 2011
United Kingdom1114629.7Aug 23, 2011
PCT Information
PCT FiledMarch 09, 2012PCT Application Number:PCT/GB2012/050526
PCT Publication Date:September 20, 2012PCT Publication Number: WO2012/123720

International Family Members for US Patent 9,592,252

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 085712 See Plans and Pricing
Australia 2012228065 See Plans and Pricing
Australia 2017203257 See Plans and Pricing
Australia 2018203694 See Plans and Pricing
Brazil 112013022653 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.